TIAA CREF Investment Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

TIAA CREF Investment Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$724K	Hold	26,410	–	–	﹤0.01%	2455
2018 Q4	$710K	Buy	26,410 +2,464	+10%	+$68.1K	﹤0.01%	2424
2018 Q3	$699K	Sell	23,946 -864	-3%	-$27.3K	﹤0.01%	2585
2018 Q2	$776K	Buy	24,810 +5,854	+31%	+$160K	﹤0.01%	2597
2018 Q1	$377K	Hold	18,956	–	–	﹤0.01%	2849
2017 Q4	$551K	Buy	+18,956	New	+$501K	﹤0.01%	2725

Other funds holding RYTM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TIAA CREF Investment Management's RYTM Position: Q1 2019 in Review

TIAA CREF Investment Management held its Rhythm Pharmaceuticals (RYTM) position steady in Q1 2019 at 26,410 shares worth $724K. The position accounts for ﹤0.01% of the portfolio, ranked #2455.

TIAA CREF Investment Management first reported a position in RYTM in Q4 2017 and has held it in 6 quarters since. The position peaked at $776K in Q2 2018. 87 funds tracked by Wall St. Rank hold RYTM as of Q1 2019.

TIAA CREF Investment Management held 26,410 shares of Rhythm Pharmaceuticals worth $724K as of Q1 2019.
TIAA CREF Investment Management left its Rhythm Pharmaceuticals share count unchanged in Q1 2019.
Rhythm Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2455 holding.
TIAA CREF Investment Management first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 6 quarters since.
TIAA CREF Investment Management's Rhythm Pharmaceuticals position peaked at $776K in Q2 2018.
87 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.